Literature DB >> 33718448

Endothelial Cells in Emerging Viral Infections.

Johanna Hol Fosse1, Guttorm Haraldsen2,3, Knut Falk1,4, Reidunn Edelmann5.   

Abstract

There are several reasons to consider the role of endothelial cells in COVID-19 and other emerging viral infections. First, severe cases of COVID-19 show a common breakdown of central vascular functions. Second, SARS-CoV-2 replicates in endothelial cells. Third, prior deterioration of vascular function exacerbates disease, as the most common comorbidities of COVID-19 (obesity, hypertension, and diabetes) are all associated with endothelial dysfunction. Importantly, SARS-CoV-2's ability to infect endothelium is shared by many emerging viruses, including henipaviruses, hantavirus, and highly pathogenic avian influenza virus, all specifically targeting endothelial cells. The ability to infect endothelium appears to support generalised dissemination of infection and facilitate the access to certain tissues. The disturbed vascular function observed in severe COVID-19 is also a prominent feature of many other life-threatening viral diseases, underscoring the need to understand how viruses modulate endothelial function. We here review the role of vascular endothelial cells in emerging viral infections, starting with a summary of endothelial cells as key mediators and regulators of vascular and immune responses in health and infection. Next, we discuss endotheliotropism as a possible virulence factor and detail features that regulate viruses' ability to attach to and enter endothelial cells. We move on to review how endothelial cells detect invading viruses and respond to infection, with particular focus on pathways that may influence vascular function and the host immune system. Finally, we discuss how endothelial cell function can be dysregulated in viral disease, either by viral components or as bystander victims of overshooting or detrimental inflammatory and immune responses. Many aspects of how viruses interact with the endothelium remain poorly understood. Considering the diversity of such mechanisms among different emerging viruses allows us to highlight common features that may be of general validity and point out important challenges.
Copyright © 2021 Fosse, Haraldsen, Falk and Edelmann.

Entities:  

Keywords:  SARS-CoV-2; emerging infections; endothelium; inflammation; vascular dysfunction and damage; virus

Year:  2021        PMID: 33718448      PMCID: PMC7943456          DOI: 10.3389/fcvm.2021.619690

Source DB:  PubMed          Journal:  Front Cardiovasc Med        ISSN: 2297-055X


  233 in total

Review 1.  Intrinsic antiviral immunity.

Authors:  Nan Yan; Zhijian J Chen
Journal:  Nat Immunol       Date:  2012-02-16       Impact factor: 25.606

2.  EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.

Authors:  Injune Kim; Young Shin Ryu; Hee Jin Kwak; So Young Ahn; Jong-Lark Oh; George D Yancopoulos; Nicholas W Gale; Gou Young Koh
Journal:  FASEB J       Date:  2002-05-21       Impact factor: 5.191

3.  AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses.

Authors:  Audrey Stéphanie Richard; Byoung-Shik Shim; Young-Chan Kwon; Rong Zhang; Yuka Otsuka; Kimberly Schmitt; Fatma Berri; Michael S Diamond; Hyeryun Choe
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

4.  Hantavirus entry: Perspectives and recent advances.

Authors:  Eva Mittler; Maria Eugenia Dieterle; Lara M Kleinfelter; Megan M Slough; Kartik Chandran; Rohit K Jangra
Journal:  Adv Virus Res       Date:  2019-08-07       Impact factor: 9.937

5.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

6.  Differential use of importin-α isoforms governs cell tropism and host adaptation of influenza virus.

Authors:  Gülsah Gabriel; Karin Klingel; Anna Otte; Swantje Thiele; Ben Hudjetz; Gökhan Arman-Kalcek; Martina Sauter; Tatiana Shmidt; Franziska Rother; Sigrid Baumgarte; Björn Keiner; Enno Hartmann; Michael Bader; George G Brownlee; Ervin Fodor; Hans-Dieter Klenk
Journal:  Nat Commun       Date:  2011-01-18       Impact factor: 14.919

7.  Lethal Nipah virus infection induces rapid overexpression of CXCL10.

Authors:  Cyrille Mathieu; Vanessa Guillaume; Amélie Sabine; Kien Chai Ong; Kum Thong Wong; Catherine Legras-Lachuer; Branka Horvat
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

8.  Molecular organization and dynamics of the fusion protein Gc at the hantavirus surface.

Authors:  Eduardo A Bignon; Amelina Albornoz; Pablo Guardado-Calvo; Félix A Rey; Nicole D Tischler
Journal:  Elife       Date:  2019-06-10       Impact factor: 8.140

9.  Vascular underpinning of COVID-19.

Authors:  Vanessa Wazny; Anthony Siau; Kan Xing Wu; Christine Cheung
Journal:  Open Biol       Date:  2020-08-27       Impact factor: 6.411

10.  The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study.

Authors:  Mengmeng Li; Liang Chen; Jingxiao Zhang; Chenglong Xiong; Xiangjie Li
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

View more
  18 in total

Review 1.  The kidney in hantavirus infection-epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management.

Authors:  Felix C Koehler; Veronica Di Cristanziano; Martin R Späth; K Johanna R Hoyer-Allo; Manuel Wanken; Roman-Ulrich Müller; Volker Burst
Journal:  Clin Kidney J       Date:  2022-01-29

2.  Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells.

Authors:  Subhayan Sur; Robert Steele; T Scott Isbell; Ranjit Ray; Ratna B Ray
Journal:  mBio       Date:  2022-05-19       Impact factor: 7.786

3.  Porcine Epidemic Diarrhea Virus Infection Disrupts the Nasal Endothelial Barrier To Favor Viral Dissemination.

Authors:  Jianda Li; Yuchen Li; Peng Liu; Xiuyu Wang; Yichao Ma; Qiu Zhong; Qian Yang
Journal:  J Virol       Date:  2022-04-18       Impact factor: 6.549

Review 4.  Platelets in Viral Infections - Brave Soldiers or Trojan Horses.

Authors:  Waltraud C Schrottmaier; Anna Schmuckenschlager; Anita Pirabe; Alice Assinger
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

5.  Interferon-alpha or -beta facilitates SARS-CoV-2 pulmonary vascular infection by inducing ACE2.

Authors:  Timothy Klouda; Yuan Hao; Hyunbum Kim; Jiwon Kim; Judith Olejnik; Adam J Hume; Sowntharya Ayyappan; Xuechong Hong; Juan Melero-Martin; Yinshan Fang; Qiong Wang; Xiaobo Zhou; Elke Mühlberger; Hongpeng Jia; Robert F Padera; Benjamin A Raby; Ke Yuan
Journal:  Angiogenesis       Date:  2021-10-29       Impact factor: 10.658

6.  High-resolution intracranial vessel wall imaging in cerebral viral infections evaluations.

Authors:  Sameer Vyas; Neha Choudhary; Manish Modi; Naveen Sankhyan; Renu Suthar; Arushi Gahlot Saini; Arun Bansal; Navneet Sharma; Paramjeet Singh
Journal:  Neuroradiology       Date:  2021-10-16       Impact factor: 2.995

7.  Endothelial cells are not productively infected by SARS-CoV-2.

Authors:  Lilian Schimmel; Keng Yih Chew; Claudia J Stocks; Teodor E Yordanov; Patricia Essebier; Arutha Kulasinghe; James Monkman; Anna Flavia Ribeiro Dos Santos Miggiolaro; Caroline Cooper; Lucia de Noronha; Kate Schroder; Anne Karine Lagendijk; Larisa I Labzin; Kirsty R Short; Emma J Gordon
Journal:  Clin Transl Immunology       Date:  2021-10-24

8.  Nitric oxide-mediated cutaneous microvascular function is not altered in young adults following mild-to-moderate SARS CoV-2 infection.

Authors:  Gabrielle A Dillon; S Tony Wolf; Lacy M Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-01-07       Impact factor: 4.733

9.  Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs.

Authors:  Geert Byttebier; Luc Belmans; Myriam Alexander; Bo E H Saxberg; Bart De Spiegeleer; Anton De Spiegeleer; Nick Devreker; Jens T Van Praet; Karolien Vanhove; Reinhilde Reybrouck; Evelien Wynendaele; David S Fedson
Journal:  Hum Vaccin Immunother       Date:  2021-05-28       Impact factor: 3.452

10.  SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity.

Authors:  Somasundaram Raghavan; Divya Borsandra Kenchappa; M Dennis Leo
Journal:  Front Cardiovasc Med       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.